Full Text
Utilization And Impact Of Value Assessment Frameworks On Payer Decisions Regarding Chimeric Antigen Receptor T-Cell Therapies

Abstract

Authors

VB Nguyen A Kanaskar K Migliaccio-Walle K Shields

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×